Cleared Traditional

K042936 - SOLUTION ADMINISTRATION WITH LUER ACCESS INJECTION SITE

K042936 is an FDA 510(k) clearance for SOLUTION ADMINISTRATION WITH LUER ACCES..., manufactured by Baxter Healthcare Corp. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 32-day FDA review.

K042936 · Baxter Healthcare Corp · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2004
Decision
32d
Days
Class 2
Risk

K042936 is an FDA 510(k) clearance for the SOLUTION ADMINISTRATION WITH LUER ACCESS INJECTION SITE. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Baxter Healthcare Corp (Round Lake, US). The FDA issued a Cleared decision on November 26, 2004 after a review of 32 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Baxter Healthcare Corp devices

FDA 510(k) Submission Details - K042936

510(k) Number K042936 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 25, 2004
Decision Date November 26, 2004
Days to Decision 32 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 129d · This submission: 32d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 791
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K042936.
F00010 - IV GRAVITY SETWITH MALE LUER SLIP
K042129 · Cedic S.R.L. · Jan 2005
LUTH-ALL SUB-Q NEEDLE SET
K042666 · Luth-All Medical Products, LLC · Dec 2004
NEXUS INTRAVENOUS TUBING SETS (NIVTS)
K041861 · Nexus Medical, LLC · Nov 2004
IV ADMINISTRATION SETS WITH ULTRABLOCK UV-RESISTANT TUBING
K041490 · B.Braun Medical, Inc. · Oct 2004
IV ADMINISTRATION SET B400 SP
K042693 · Codan US Corp. · Oct 2004
CLEO 90 INFUSION SET
K042172 · Smiths Medical MD, Inc. · Oct 2004